Dr Anne Phillips - Medicine Development Leader for GlaxoSmithKline

On the challenges of multicenter, multisite R&D, and learning lessons from Avandia.

Dr. Anne Phillips was vice president of clinical development at GlaxoSmithKline during the Avandia trial and fallout, and now leads medicine development in oncology drug research and development.

Thus, Anne is perfectly placed to explain the very modern challenges of big pharma: how you coordinate all elements of multicenter, multisite R&D; and how you ensure that a company moves forward after a public dressing down.

In this interview, Anne talks with Adam Burns about:

The key challenges of modern drug deliver
Managing multicenter, multisite research and development
R&D or M&A: getting the strategy right
Avandia: prevention and communication

Category:

People & Blogs

Tags:

• Research and Development
• R&D
• Pharmaceutical
• Avandia
• Medicine Development
• GlaxoSmithKline
• GSK
• MeettheBoss